You need to unblock this content by setting your broser.
ブラウザーはこの内容をブロックしないように設定してください。

INFO:
Siemens Healthineers announces the Food and Drug Administration’s premarket approval for the tomosynthesis or three-dimensional breast imaging technology of the MAMMOMAT B.brilliant—the first completely redesigned mammography platform in over a decade. 🌟 Wide angle TOMO (3D) in less than 5 seconds – the widest angle available 🌟 Exceptional image quality with Premia reconstructed powered by AI 🌟 UltraHD image reconstruction technology reduces metal artifacts for crisp visualization of calcifications 🌟 Did we mention how beautifully brilliant it is?! Learn more about the new B.brilliant system today! https://lnkd.in/eDT7rGFg
Siemens Healthineers announces the Food and Drug Administration’s premarket approval for the tomosynthesis or three-dimensional breast imaging technology of the MAMMOMAT B.brilliant—the first… | Cassling